Patent details
LUC00222 Product Name: Pemigatinib or a pharmaceutically acceptable salt thereof
Basic Information
- Publication number:
- LUC00222
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP137831251
- Legal Status:
- Inactive
- Application number:
- LUC00222
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/21/1535
- Marketing Authorization Type:
- Marketing Authorization Date:
- 29/03/2021
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 10/09/2021
- First Marketing Authorization date:
- 29/03/2021
- Grant date:
- 04/10/2024
- Activation date:
- Publication date:
- 13/09/2021
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 29/03/2036
- SPC Extension Expiration:
- 29/03/2036
- Rejection date:
- Withdrawal date:
Owner
- From:
- 10/09/2021
- Name:
- Incyte Holdings Corporation
- Address:
- 1801 Augustine Cut-Off, Wilmington, DE 19803, United States (US)
Agent
- Name:
- Dennemeyer & Associates S.A.
- From:
- 10/09/2021
- Address:
- 55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2021/11
- Publication date:
- 08/10/2021
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2024/13
- Publication date:
- 05/11/2024
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Annual Fees
- Annual Fee Due Date:
- 30/06/2033
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 10/09/2021 | Summary of the product caracteristics | 36 |
| 10/09/2021 | General Document | 1 |
| 13/09/2021 | Outgoing Correspondence | 1 |
| 10/09/2021 | MA publication | 9 |
| 10/09/2021 | Marketing authorization | 4 |
| 10/09/2021 | Application Form | 5 |
| 13/09/2021 | Publication | 1 |
| 04/10/2024 | Publication | 1 |
| 04/10/2024 | Certificate | 1 |
| 04/10/2024 | Outgoing Correspondence | 1 |